BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12890330)

  • 1. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
    Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
    Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
    Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
    J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
    Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study.
    Latouche S; Lacube P; Maury E; Bolognini J; Develoux M; Girard PM; Godet C; Lebrette MG; Mayaud C; Guillot J; Roux P
    Med Mycol; 2003 Dec; 41(6):533-7. PubMed ID: 14725329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
    Stein CR; Poole C; Kazanjian P; Meshnick SR
    Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
    Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
    J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism.
    Helweg-Larsen J; Eugen-Olsen J; Lundgren B
    Scand J Infect Dis; 2000; 32(5):481-3. PubMed ID: 11055650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
    Armstrong W; Meshnick S; Kazanjian P
    Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L; Morris AM; Beard CB
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract]   [Full Text] [Related]  

  • 11. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV.
    Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O
    J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
    Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
    Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of restriction fragment length polymorphism to detect dihydropteroate synthase gene mutations in strains of Pneumocystis jirovecii isolated in Poland].
    Gołab E
    Med Dosw Mikrobiol; 2007; 59(2):177-82. PubMed ID: 17929415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.
    Huang L; Beard CB; Creasman J; Levy D; Duchin JS; Lee S; Pieniazek N; Carter JL; del Rio C; Rimland D; Navin TR
    J Infect Dis; 2000 Oct; 182(4):1192-8. PubMed ID: 10979917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
    Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
    Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia].
    Calderón E; de la Horra C; Montes-Cano MA; Respaldiza N; Martín-Juan J; Varela JM
    Med Clin (Barc); 2004 May; 122(16):617-9. PubMed ID: 15142509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.